62 related articles for article (PubMed ID: 25681288)
1. Paclitaxel tumor-priming enhances siRNA delivery and transfection in 3-dimensional tumor cultures.
Wong HL; Shen Z; Lu Z; Wientjes MG; Au JL
Mol Pharm; 2011 Jun; 8(3):833-40. PubMed ID: 21417439
[TBL] [Abstract][Full Text] [Related]
2. Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression.
Li Z; Wang H; Yin H; Bennett C; Zhang HG; Guo P
Sci Rep; 2018 Oct; 8(1):14644. PubMed ID: 30279553
[TBL] [Abstract][Full Text] [Related]
3. Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles.
Zhuang J; Gong H; Zhou J; Zhang Q; Gao W; Fang RH; Zhang L
Sci Adv; 2020 Mar; 6(13):eaaz6108. PubMed ID: 32258408
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle drug delivery systems for synergistic delivery of tumor therapy.
Chen D; Liu X; Lu X; Tian J
Front Pharmacol; 2023; 14():1111991. PubMed ID: 36874010
[TBL] [Abstract][Full Text] [Related]
5. Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells.
Eljack S; Allard-Vannier E; Misericordia Y; Hervé-Aubert K; Aubrey N; Chourpa I; Faggad A; David S
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432729
[TBL] [Abstract][Full Text] [Related]
6. An Overview of siRNA Delivery Strategies for Urological Cancers.
Halib N; Pavan N; Trombetta C; Dapas B; Farra R; Scaggiante B; Grassi M; Grassi G
Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456552
[TBL] [Abstract][Full Text] [Related]
7. Novel Combination Therapies for the Treatment of Bladder Cancer.
Peng M; Xiao D; Bu Y; Long J; Yang X; Lv S; Yang X
Front Oncol; 2020; 10():539527. PubMed ID: 33585182
[TBL] [Abstract][Full Text] [Related]
8. Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.
Raven PA; D'Costa NM; Moskalev I; Tan Z; Frees S; Chavez-Munoz C; So AI
Am J Clin Exp Urol; 2018; 6(6):245-259. PubMed ID: 30697580
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition and chemo-radiosensitization of esophageal squamous cell carcinoma by survivin-shRNA lentivirus transfection.
Zhou C; Zhang L; Xu P
Oncol Lett; 2018 Oct; 16(4):4813-4820. PubMed ID: 30250546
[TBL] [Abstract][Full Text] [Related]
10. Potential Applications of Nanotechnology in Urological Cancer.
He MH; Chen L; Zheng T; Tu Y; He Q; Fu HL; Lin JC; Zhang W; Shu G; He L; Yuan ZX
Front Pharmacol; 2018; 9():745. PubMed ID: 30038573
[TBL] [Abstract][Full Text] [Related]
11. Survivin expression in head and neck squamous cell carcinomas is frequent and correlates with clinical parameters and treatment outcomes.
Münscher A; Prochnow S; Gulati A; Sauter G; Lörincz B; Blessmann M; Hanken H; Böttcher A; Clauditz TS
Clin Oral Investig; 2019 Jan; 23(1):361-367. PubMed ID: 29671054
[TBL] [Abstract][Full Text] [Related]
12. siRNA-loaded poly(histidine-arginine)
Sun P; Huang W; Kang L; Jin M; Fan B; Jin H; Wang QM; Gao Z
Int J Nanomedicine; 2017; 12():3221-3234. PubMed ID: 28458542
[TBL] [Abstract][Full Text] [Related]
13. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
[TBL] [Abstract][Full Text] [Related]
14. Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy.
Lee J; Saw PE; Gujrati V; Lee Y; Kim H; Kang S; Choi M; Kim JI; Jon S
Theranostics; 2016; 6(2):192-203. PubMed ID: 26877778
[TBL] [Abstract][Full Text] [Related]
15. Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.
Au JL; Yeung BZ; Wientjes MG; Lu Z; Wientjes MG
Adv Drug Deliv Rev; 2016 Feb; 97():280-301. PubMed ID: 26686425
[TBL] [Abstract][Full Text] [Related]
16. Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.
Cui M; Au JL; Wientjes MG; O'Donnell MA; Loughlin KR; Lu Z
J Urol; 2015 Jul; 194(1):230-7. PubMed ID: 25681288
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
[TBL] [Abstract][Full Text] [Related]
18. Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C.
Verma A; Degrado J; Hittelman AB; Wheeler MA; Kaimakliotis HZ; Weiss RM
BJU Int; 2011 Apr; 107(7):1154-61. PubMed ID: 20735383
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
